Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cross-validation of genes potentially associated with overall survival and drug resistance in ovarian cancer

27 Mar 2017

Abstract excerpt

Ovarian cancer is the leading cause of death among malignancies of the female reproductive system. The 5-year survival rates of ovarian cancer (OC) patients are very poor as a result of recurrent disease and emergence of drug resistance; thus, studies to find predictive markers and factors for drug resistance are ongoing. In the present study, based on the microarrays from The Cancer Genome Atlas (TCGA), and the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Mechanisms and Therapy
Share to Cancer-related molecular mechanisms research
Share to Ovarian cancer diagnosis and treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 28350120
DOI: 10.3892/or.2017.5534

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cross-validation of genes potentially associated with overall survival and drug resistance in ovarian cancerPMID 28350120Read ↗

Microarray‐based identification of genes associated with prognosis and drug resistance in ovarian cancerSemantic proximity Read ↗

A risk model of gene signatures for predicting platinum response and survival in ovarian cancerSemantic proximity Read ↗

MEOX2 mediates cisplatin resistance in ovarian cancer via E2F target and DNA repair pathwaysSemantic proximity Read ↗

Gene networks and expression quantitative trait loci associated with platinum-based chemotherapy response in high-grade serous ovarian cancerSemantic proximity Read ↗

Identification of metabolism-associated molecular subtype in ovarian cancer.Semantic proximity Read ↗

Construction and Validation of a Platinum Sensitivity Predictive Model With Multiple Genomic Variations for Epithelial Ovarian CancerSemantic proximity Read ↗

A Novel Platinum Resistance-related Immune Gene Signature for Overall Survival Prediction in Patients with Ovarian CancerSemantic proximity Read ↗

Leveraging Genomics, Transcriptomics, and Epigenomics to Understand the Biology and Chemoresistance of Ovarian CancerSemantic proximity Read ↗

Large-scale integrated analysis of ovarian cancer tumors and cell lines identifies an individualized gene expression signature for predicting response to platinum-based chemotherapySemantic proximity Read ↗

Identification of prognostic genes after platinum-based chemotherapy in ovarian cancerSemantic proximity Read ↗

Identifying the Role of Oxidative Stress‐Related Genes as Prognostic Biomarkers and Predicting the Response of Immunotherapy and Chemotherapy in Ovarian CancerSemantic proximity Read ↗

Gene Expression Profiles in Ovarian Cancer Tissues as a Potential Tool to Predict Platinum-based Chemotherapy ResistanceSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.